Anbinder Ana Lia, Junqueira Juliana Campos, Mancini Maria Nadir G, Balducci Ivan, Rocha Rosilene Fernandes da, Carvalho Yasmin Rodarte
Department of Dentistry, University of Taubaté, Rua dos Operários 9, 12020-270 Taubaté, SP, Brazil.
Braz Dent J. 2006;17(4):267-73. doi: 10.1590/s0103-64402006000400001.
The purpose of this study was to evaluate the effects of simvastatin, by oral or subcutaneous administration, on tibial defects regeneration and blood cholesterol level in rats. A surgical defect was made on the right tibia of 40 male animals assigned to 4 groups (n=10), based on two routes of administration and on the use or not of simvastatin: subcutaneous injection of simvastatin (7 mg/kg) (group AT) or only the vehicle of drug suspension (group AC), above the defect area, for 5 days; and 20 mg/kg of simvastatin macerated on water (group BT) or only water (group BC), orally, daily, during the whole observation period. The animals were sacrificed after 15 or 30 days, when blood samples were analyzed to check plasma cholesterol levels. Tibiae were removed and, after decalcification and routine laboratorial processing, histological and histomorphometrical analyses were carried out. ANOVA was used for statistical analysis at 5% significance level. The histological and histomorphometrical analyses showed significant differences only between the experimental periods (p<0.05). Animals sacrificed after 30 days showed better bone repair (p<0.05). There was no statistically significant difference (p>0.05) for blood cholesterol levels between the groups. In conclusion, simvastatin administration either orally or subcutaneously did not improve bone repair of experimental tibial defects and did not alter blood cholesterol levels in rats.
本研究的目的是评估口服或皮下注射辛伐他汀对大鼠胫骨缺损再生及血液胆固醇水平的影响。将40只雄性动物分为4组(每组n = 10),根据给药途径及是否使用辛伐他汀,在其右胫骨制造手术缺损:在缺损区域上方皮下注射辛伐他汀(7 mg/kg)(AT组)或仅注射药物悬浮液的赋形剂(AC组),持续5天;在整个观察期内,每天口服20 mg/kg辛伐他汀浸于水中的溶液(BT组)或仅口服水(BC组)。在15天或30天后处死动物,采集血样分析血浆胆固醇水平。取出胫骨,经脱钙及常规实验室处理后,进行组织学和组织形态计量学分析。采用方差分析进行统计分析,显著性水平为5%。组织学和组织形态计量学分析显示仅在实验周期之间存在显著差异(p<0.05)。30天后处死的动物显示出更好的骨修复效果(p<0.05)。各组之间血液胆固醇水平无统计学显著差异(p>0.05)。总之,口服或皮下注射辛伐他汀均未改善实验性胫骨缺损的骨修复,也未改变大鼠的血液胆固醇水平。